Covered recipient · General Payments record
SHARMIN NURANI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$238.21
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $238.21 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $170.16 | 14 |
| Genentech USA, Inc. | $35.44 | 2 |
| Celgene Corporation | $32.61 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $238.21 | 18 |
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $17.88 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101163930 | CMS |
| Celgene Corporation | $14.73 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101163938 | CMS |
| Genentech USA, Inc. | $13.14 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133187403 | CMS |
| Genentech USA, Inc. | $22.30 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133187397 | CMS |
| UCB, Inc. | $7.52 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201594 | CMS |
| UCB, Inc. | $7.50 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201598 | CMS |
| UCB, Inc. | $10.92 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201602 | CMS |
| UCB, Inc. | $7.63 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201606 | CMS |
| UCB, Inc. | $0.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201611 | CMS |
| UCB, Inc. | $24.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201615 | CMS |
| UCB, Inc. | $8.13 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201620 | CMS |
| UCB, Inc. | $18.22 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201624 | CMS |
| UCB, Inc. | $21.19 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201629 | CMS |
| UCB, Inc. | $2.15 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201633 | CMS |
| UCB, Inc. | $18.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201637 | CMS |
| UCB, Inc. | $16.92 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201641 | CMS |
| UCB, Inc. | $1.88 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201645 | CMS |
| UCB, Inc. | $23.49 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143201650 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.